LEADER 00731nam0-22002891i-450- 001 990000025730403321 035 $a000002573 035 $aFED01000002573 035 $a(Aleph)000002573FED01 035 $a000002573 100 $a20011111d--------km-y0itay50------ba 101 0 $aita 105 $ay-------001yy 200 1 $aAscenseurs et monte-charge$fG. Texier. 210 $aParis$cEditions Eyrolles$d1957 215 $a143 p.$cill.$d24 cm 610 0 $aMontacarichi 610 0 $aAscensori 676 $a621.8 700 1$aTexier,$bGeorges 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990000025730403321 952 $a13 C 54 13$b22694$fFINBC 959 $aFINBC 997 $aUNINA DB $aING01 LEADER 01769ngm 2200481I 450 001 9910713367403321 005 20200330125354.0 035 $a(CKB)5470000002499968 035 $a(OCoLC)1147704060 035 $a(EXLCZ)995470000002499968 100 $a20200330d2019 ua v 101 0 $aeng 135 $aur||||||||||| 181 $ctdi$2rdacontent 182 $cv$2rdamedia 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$a(Almost) everything you wanted to know about NIA funding but were afraid to ask /$fRobin Barr 210 1$a[Bethesda, Md.] :$cNational Institute on Aging,$d2019. 215 $a1 online resource (streaming video file) 300 $a"Webinar, March 26, 2019." 330 $aVideo recording of a presentation by Dr. Robin Barr on NIA funding priorities, funding opportunities, and tips on properly submitting an application. 517 1 $aHow to get a grant from NIA 517 3 $aAlmost everything you wanted to know about National Institute on Aging funding but were afraid to ask 606 $aAging$xResearch grants$zUnited States 606 $aFederal aid to research$zUnited States 606 $aGrants-in-aid 606 $aStreaming video 608 $aNonfiction films.$2lcgft 608 $aDocumentary films.$2lcgft 608 $aVideo recordings.$2lcgft 615 0$aAging$xResearch grants 615 0$aFederal aid to research 615 0$aGrants-in-aid. 615 0$aStreaming video. 700 $aBarr$b Robin$01409142 712 02$aNational Institute on Aging, 801 0$bGPO 801 1$bGPO 906 $aBOOK 912 $a9910713367403321 996 $aAlmost) everything you wanted to know about NIA funding but were afraid to ask$93494794 997 $aUNINA LEADER 03748nam 22006135 450 001 9910502646403321 005 20251113194037.0 010 $a3-030-76263-7 024 7 $a10.1007/978-3-030-76263-6 035 $a(CKB)5360000000049929 035 $a(MiAaPQ)EBC6745523 035 $a(Au-PeEL)EBL6745523 035 $a(OCoLC)1273980289 035 $a(PPN)258300205 035 $a(DE-He213)978-3-030-76263-6 035 $a(EXLCZ)995360000000049929 100 $a20211005d2021 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aCancer Nanotheranostics $eVolume 2 /$fedited by Muthupandian Saravanan, Hamed Barabadi 205 $a1st ed. 2021. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2021. 215 $a1 online resource (379 pages) $cillustrations 225 1 $aNanotechnology in the Life Sciences,$x2523-8035 311 08$a3-030-76262-9 320 $aIncludes bibliographical references. 327 $aPreface -- Nanotheranostics -- Multifunctional Nanoparticles for Targeting Cancer Nanotheranostics -- Nano-Oncology -- Cancer-Targeted Nanotheranostics -- Nanotheranostics -- Cancer Nano-Immunotherapy -- Recent Advances in Lipid-Based Nanoformulations for Breast Cancer Theranostics -- Nanoparticle for Photoresponsive Minimal-Invasive Cancer Therapy -- Biologically Synthesized Plant-Derived Nanomedicines and their In-Vitro In-Vivo Toxicity Studies in Various Cancer Therapeutics -- Nanoerythrosome -- Role of Artificial Intelligence in Cancer Nanotheranostics -- Limitations of Current Cancer Nanotheranositcs -- Safety of nanobiomaterials for Cancer Nanotheranostics -- Index. 330 $aCancer Nanotheranostics, Volume 2 continues the discussion of the important work being done in this field of cancer nanotechnology. The contents of these two volumes are explained in detail as follows. In the first volume of Cancer Nanotheranostics, we discussed the role of different nanomaterials for cancer therapy including lipid-based nanomaterials, protein and peptide-based nanomaterials, polymer-based nanomaterials, metal-organic nanomaterials, porphyrin-based nanomaterials, metal-based nanomaterials, silica-based nanomaterials, exosome-based nanomaterials, and nano-antibodies. This important second volume discusses nano-based diagnosis of cancer, nano-oncology for clinical applications, nano-immunotherapy, nano-based photothermal cancer therapy, nanoerythrosomes for cancer drug delivery, regulatory perspectives of nanomaterials, limitations of cancer nanotheranostics, safety of nanobiomaterials for cancer nanotheranostics, multifunctional nanomaterials for targeting cancer nanotheranostics, and the role of artificial intelligence in cancer nanotheranostics. Volume 2 is a vital continuation of this two-volume set. Together, these two volumes create a comprehensive and unique examination of this important area of research. 410 0$aNanotechnology in the Life Sciences,$x2523-8035 606 $aCancer 606 $aNanomedicine 606 $aNanobiotechnology 606 $aCancer Nanotechnology 606 $aCancer Biology 606 $aNanobiotechnology 615 0$aCancer. 615 0$aNanomedicine. 615 0$aNanobiotechnology. 615 14$aCancer Nanotechnology. 615 24$aCancer Biology. 615 24$aNanobiotechnology. 676 $a616.9940072 700 $aSaravanan$b Muthupandian$01072527 702 $aBarabadi$b Hamed 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910502646403321 996 $aCancer Nanotheranostics$92568812 997 $aUNINA